Mark Leung is an associate in Dentons' Hong Kong Corporate Finance practice.

Mark's primary focus is on corporate finance transactions, including initial public offerings, mergers and acquisitions, compliance matters for companies listed on the Hong Kong Stock Exchange and other commercial transactions.

Before joining Dentons, Mark practiced with a leading US law firm in Hong Kong.


  • Hengxing Gold Holding Co. Ltd.: Represented in its HK$330 million (US$47 million) listing on the Main Board of the Hong Kong Stock Exchange.
  • Shanghai Haohai Biological Technology Co. Ltd.: Represented in its US$300 million H-shares listing on the Main Board of the Hong Kong Stock Exchange.
  • Pharmaceutical company: Represented in its sale of 100 percent of the equity of a Hong Kong subsidiary to a Holland-based listed company.
  • Confidential client: Represented a British Virgin Islands-incorporated company in its sale of a leading travel agency in Hong Kong.

Activities and Affiliations


  • Law Society of Hong Kong

Prior and Present Employment

  • Associate, O'Melveny & Myers, 2016‒2017
  • Trainee solicitor, O'Melveny & Myers, 2014‒2016